The
digital dose inhaler market has witnessed significant growth owing to the
growing prevalence of respiratory diseases like asthma and chronic obstructive
pulmonary disease (COPD). Digital dose inhalers are easy-to-use, portable
devices that help deliver the right dose of medication to the lungs in the form
of mist. They contain built-in sensors that can track medication usage and send
real-time usage data to a linked smartphone. This allows patients to monitor
their condition and dosage intake under the supervision of their physician.
The Global Digital Dose Inhaler Market is estimated to
be valued at US$ 18.33 Bn in 2024 and is expected to exhibit a CAGR of 19.%
over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the digital dose inhaler market are 3M,
AstraZeneca, GLENMARK PHARMACEUTICALS LTD., Novartis AG, Sensirion AG,
Propeller Health, OPKO Health, Inc., Teva Pharmaceutical Industries Ltd.,
BEXIMCO Pharmaceuticals, GSK plc., Mundhipharma International, Honeywell
International Inc., Veranex, Cognita Labs. Digital dose inhalers from these
players help empower patients to remotely track medication use history and
receive alerts to improve compliance.
The growing demand in the market can be attributed to the increasing healthcare
costs of respiratory diseases and rising awareness about digital therapeutics.
Digital
Dose Inhalers Market Size provide accurate dosing and help avoid over-
or under-use of medication. This significantly improves health outcomes and
lowers overall treatment costs of chronic respiratory conditions.
The global expansion of the digital dose inhaler market has been driven by the
growing elderly population who are more prone to respiratory illnesses as well
as increasing adoption of digital health solutions. Various regions like North
America, Europe, Asia Pacific and Latin America provide lucrative opportunities
for players as a result of growing healthcare expenditures, fast adoption of
advanced technologies and rising incidents of lung diseases.
Market Key Trends
One of the key trends in the digital dose inhaler market is the growing
popularity of combination inhalers that allow delivery of two different drugs
through a single inhalation. This improves medication adherence and control of
respiratory symptoms. Manufacturers are also offering novel designs, portable
sizes, and synchronized solutions with smartphones to enhance patient
experience and encourage voluntary usage monitoring at home care settings.
Furthermore, integration of 3D printing, AI and IoT capabilities is expected to
transform digital dose inhaler devices with more features for personalized care
in respiratory disease management.
Porter’s Analysis
Threat of new entrants: It is moderate as high capital
requirements and stringent regulations set barriers for new companies to enter
the market. However, growth opportunities attract new small players.
Bargaining power of buyers: It is moderate to high as large number of buyers
are available and they demand new features and better pricing. Buyers can also
easily switch to substitute products.
Bargaining power of suppliers: It is moderate as suppliers have differentiation
in their products and few stakeholders dominate the supply landscape. However,
availability of substitutes keeps their power in check.
Threat of new substitutes: It is moderate to high as alternative delivery
methods and new respiratory drug therapies can be developed that reduce patient
reliance on inhalers over time.
Competitive rivalry: It is high as the market is growing and top players
compete on new product features, pricing and marketing. Brand loyalty is also
strong among patients and doctors.
Geographical Regions
North America region accounts for over 35% of the total digital dose inhaler
market value currently led by the US market. Strong awareness, favorable
reimbursement policies and presence of top players have propelled the region's
market size.
Asia Pacific region is expected to see the fastest market growth during the
forecast period with a CAGR of around 25%. Rapid economic development, rising
respiratory disease prevalence, growing health awareness and improving access
are driving the regional market particularly in China and India.
Get more insights on Digital
Dose Inhalers Market
Vaagisha
brings over three years of expertise as a content editor in the market research
domain. Originally a creative writer, she discovered her passion for editing,
combining her flair for writing with a meticulous eye for detail. Her ability
to craft and refine compelling content makes her an invaluable asset in
delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
Comments
Post a Comment